Physician profile
Nancy Petit
NPI 1710927488
$514.16
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $122 · 2020: $65.63 · 2021: $128 · 2022: $81.98 · 2023: $116.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $116.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $115.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $121.48 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $115.82 | 2023 | Rexulti |
| Allergan, INC. | $43.81 | 2019-2020 | |
| Pfizer INC. | $27.11 | 2019-2020 | |
| Dysis Medical, INC. | $26.36 | 2020 | |
| Covidien LP | $24.61 | 2019 | |
| Ethicon US, LLC | $23.99 | 2021 | |
| Therapeuticsmd, INC. | $23.67 | 2019 | |
| Myovant Sciences INC. | $17.99 | 2021 | |
| Astellas Pharma US INC | $17.90 | 2021 | |
| Boston Scientific Corporation | $16.20 | 2019 | |
| Abbvie INC. | $16.16 | 2021 | |
| Avion Pharmaceuticals | $13.44 | 2020 | |
| Evofem Biosciences, INC. | $12.90 | 2021 | |
| Lupin INC. | $12.72 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nancy Petit listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.